A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy
Clinical Trial Grant
Administered By
Neurology, Epilepsy and Sleep
Awarded By
Xenon Pharmaceuticals Inc.
Start Date
July 13, 2023
End Date
December 31, 2028
Administered By
Neurology, Epilepsy and Sleep
Awarded By
Xenon Pharmaceuticals Inc.
Start Date
July 13, 2023
End Date
December 31, 2028